权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Polyamine and Glutamate Driven Interactions in the Glioblastoma-Brain Microenvironment

胶质母细胞瘤-脑微环境中多胺和谷氨酸驱动的相互作用

基本信息

批准号：
10450174
负责人：
Scott Michael Welford
金额：
$ 34.07万
依托单位：
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-08-07 至 2026-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10450174
关键词：
Adopted Apoptosis Architecture Blood Brain Brain Glioblastoma Brain Injuries Brain Neoplasms CRISPR/Cas technology Cell Death Cells Cessation of life Clinical Clustered Regularly Interspaced Short Palindromic Repeats Cognition Cognitive Cognitive deficits Conformal Radiotherapy Cranial Irradiation DNA Repair Gene Dendrites Disease Dose-Limiting Effectiveness Electrophysiology (science)Electroporation Embryo Enzymes Event Excitatory Amino Acid Antagonists Exposure to Flow Cytometry Frequencies Gene Expression Genetic Models Glioblastoma Glioma Glutamate Metabolism Pathway Glutamate Receptor Glutamates Glutamine Hippocampus (Brain)Hour Immunocompetent Immunotherapy Impaired cognition Ionizing radiation Lead Lesion Link Mediating Mediator of activation protein Modality Modeling Morbidity - disease rate Mus N-Methyl-D-Aspartate Receptors Nature Nervous System Trauma Neuraxis Neurons Neurotransmitters Normal tissue morphology Organ Pathway interactions Patient-Focused Outcomes Patients Pharmacology Phosphorylation Play Polyamines Protons Radiation Radiation Interaction Radiation Tolerance Radiation exposure Radiation induced damage Radiation therapy Radiation-Sensitizing Agents Radiosensitization Receptor Signaling Resistance Roentgen Rays Role Signal Pathway Signal Transduction Slice Specificity Structure System Therapeutic Time Toxic effect Tumor Suppressor Genes adverse outcome autocrine base cell type excitotoxicity extracellular gene therapy genome editing glutamatergic signaling ifenprodil improved improved outcome in utero inhibitor innovation insight irradiation neoplastic cell neuroinflammation neuron loss neurotoxicity neutralizing monoclonal antibodies novel particle therapy preclinical study protective effect radiation resistance radioresistant standard of care therapy resistant tumor tumor growth

项目摘要

Project Summary Radiotherapy is a standard modality for brain lesions, and has led improvements in patient outcome through the addition of high precision stereotactic delivery and more recently particle therapy. While patients are benefiting from increasing survival times, cognitive complications develop with increased frequency and are thus challenging treatment paradigms. Biologically, the mechanisms of neurotoxicity from ionizing radiation are unclear. Recent studies have highlighted exquisite sensitivity to an organ that has been traditionally thought to be radioresistant due to its non-proliferative nature. Dendrite remodeling, neuroinflammation, and excitotoxicity are all elevated following exposure to ionizing radiation, and are thought to contribute to decreased cognition. In the current application, we propose that excessive glutamate signaling is a key driver of cognitive damage from radiation. In addition, our group has been investigating the role of the polyamine pathway in radiation resistance of tumor cells. Both glutamate and polyamines are found to be elevated in brain tumors, an induced secretion is evident after exposure to radiation. In mechanistic studies, we implicate the NMDAR NR2B subunit as a specific target of glutamate and polyamines that leads to neurotoxicity. We hypothesize that blocking glutamate-receptor signaling with a specific glutamate receptor antagonist will reduce CNS damage due to radiation, and sensitize tumor cells to radiation induced death, and therefore improve patient outcomes.

项目总结